Revvity Inc. (RVTY) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Revvity, Inc. provides health sciences solutions, technologies, and services.

Total Revenue Chart for Revvity Inc.

Revvity Inc. (RVTY) revenue for FY2025 was USD 2.9B, a 3.7% change from FY2024. Revvity Inc.'s revenue grew from USD 1.2B in 1985 to USD 2.9B in 2025 (147.3% over 40 years). Earnings per share grew from USD 2.04 in 2019 to USD 4.50 in 2022 (120.6%). Revenue compound annual growth rate: 5-year CAGR of -5.5%, 10-year CAGR of 3.1%, 20-year CAGR of 3.4%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$17.52B
Implied Share Price
$157.00
Enterprise Value
$19.84B
Revenue (TTM)
$2.91B
EBITDA
$875.83M
Profit Margin
8.16%
Trailing P/E
75.12
Forward P/E
26.67
Price/Book (MRQ)
2.42
Price/Sales (TTM)
6.02
EV/EBITDA
25.69
EV/Revenue
6.81
Dividend Yield
0.17%
Book Value
$64.78
Free Cash Flow (FY2025)
$508.25M
Free Cash Flow Yield
2.90%

Snapshot as of 1st November 2026 — not point-in-time controlled, may lag the live market by a few days.